The risk of new onset depression in association with influenza - A population-based observational study

Brain, Behavior, and Immunity

Volumn 53, Issue , 2016, Pages 131-137

  Bornand, Delia ^a,b   Toovey, Stephen ^c   Jick, Susan S ^d   Meier, Christoph R ^a,b,d  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^d BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Infectious disease; Influenza infection; Major depression; Observational study

Indexed keywords

ANTIBIOTIC AGENT; BENZODIAZEPINE DERIVATIVE; CORTICOSTEROID; INFLUENZA VACCINE;

ADULT; AGE DISTRIBUTION; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CASE CONTROL STUDY; CLINICAL PRACTICE; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; INFLUENZA; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBSERVATIONAL STUDY; POPULATION RESEARCH; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SMOKING; YOUNG ADULT; ADOLESCENT; AGED; CHILD; FACTUAL DATABASE; INFLUENZA A VIRUS; ISOLATION AND PURIFICATION; MAJOR DEPRESSION; ODDS RATIO; PSYCHOLOGY; VERY ELDERLY; VIROLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHILD; COMORBIDITY; DATABASES, FACTUAL; DEPRESSION; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; MALE; MIDDLE AGED; ODDS RATIO; RISK FACTORS;

EID: 84959541807     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2015.12.005     Document Type: Article

References (51)

1. Anisman H., Merali Z. Cytokines, stress and depressive illness: brain-immune interactions. Ann. Med. 2003, 35:2-11.
2. Baek J.H., Eisner L.R., Nierenberg A.A. Smoking and suicidality in subjects with major depressive disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). J. Affect. Disord. 2013, 150:1158-1166.
3. Bakish D. New standard of depression treatment: remission and full recovery. J. Clin. Psychiatry 2001, 62(Suppl. 26):5-9.
4. Baraldi S., Hepgul N., Mondelli V., Pariante C.M. Symptomatic treatment of interferon-alpha-induced depression in hepatitis C: a systematic review. J. Clin. Psychopharmacol. 2012, 32:531-543.
5. Berk M., Williams L.J., Jacka F.N., O'Neal A., Pasco J.A., et al. So depression is an inflammatory disease, but where does the inflammation come from?. BMC Med. 2013, 11:200.
6. Berlin I. Endocrine and metabolic effects of smoking cessation. Curr. Med. Res. Opin. 2009, 25:527-534.
7. Cai B., Xu W., Bortnichak E., Watson D.J. An algorithm to identify medical practices common to both the General Practice Research Database and The Health Improvement Network database. Pharmacoepidemiol. Drug Saf. 2012.
8. Clark I.A., Vissel B. Inflammation-sleep interface in brain disease: TNF, insulin, orexin. J. Neuroinflammation 2014, 11:51.
9. Collins P.Y., Patel V., Joestl S.S., et al. Grand challenges in global mental health. Nature 2011, 475:27-30.
10. Dantzer R. Cytokine-induced sickness behavior: mechanisms and implications. Ann. N. Y. Acad. Sci. 2001, 933:222-234.
11. Dauvilliers Y., Lopez R., Ohayon M., et al. Hypersomnia and depressive symptoms: methodological and clinical aspects. BMC Med. 2013, 11:78.
12. Darwish I., Mubareka S., Liles W.C. Immunomodulatory therapy for severe influenza. Expert Rev. Anti Infect. Ther. 2011, 9:807-822.
13. Dickens C., Cherrington A., McGowan L. Depression and health-related quality of life in people with coronary heart disease: a systematic review. Eur. J. Cardiovasc. Nurs. 2012.
14. Dowlati Y., Herrmann N., Swardfager W., et al. A meta-analysis of cytokines in major depression. Biol. Psychiatry 2010, 67:446-457.
15. Essau C.A., Lewinsohn P.M., Seeley J.R., Sasagawa S. Gender differences in the developmental course of depression. J. Affect. Disord. 2010, 127:185-190.
16. Gharbawy D., Tadrous M., Suda K. Does depression lead to influenza? A systematic literature analysis. J. Affect. Disord. 2012, 138(1-2):41-45.
17. Glassman A.H., Covey L.S., Stetner F., Rivelli S. Smoking cessation and the course of major depression: a follow-up study. Lancet 2001, 357:1929-1932.
18. Hui D.S., Lee N., Chan P.K. Adjunctive therapies and immunomodulatory agents in the management of severe influenza. Antiviral Res. 2013, 98:410-416.
19. Irwin M., Rinetti G., Redwine L., Motivala S., Dang J., et al. Nocturnal proinflammatory cytokine-associated sleep disturbances in abstinent African American alcoholics. Brain Behav. Immun. 2004, 18:349-360.
20. Jang H., Boltz D., McClaren J., et al. Inflammatory effects of highly pathogenic H5N1 influenza virus infection in the CNS of mice. J. Neurosci. 2012, 32:1545-1559.
21. Jiang M., Qin P., Yang X. Comorbidity between depression and asthma via immune-inflammatory pathways: a meta-analysis. J. Affect. Disord. 2014, 166:22-29.
22. Jick S.S., Kaye J.A., Vasilakis-Scaramozza C., et al. Validity of the general practice research database. Pharmacotherapy 2003, 23:686-689.
23. Joynt K.E., Whellan D.J., O'Connor C.M. Depression and cardiovascular disease: mechanisms of interaction. Biol. Psychiatry 2003, 54:248-261.
24. Khairova R.A., Machado-Vieira R., Du J., Manji H.K. A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder. Int. J. Neuropsychopharmacol. 2009, 12:561-578.
25. Kaiser L., Fritz R.S., Straus S.E., Gubareva L., Hayden F.G. Symptom pathogenesis during acute influenza: interleukin-6 and other cytokine responses. J. Med. Virol. 2001, 64:262-268.
26. Kreijtz J.H., Fouchier R.A., Rimmelzwaan G.F. Immune responses to influenza virus infection. Virus Res. 2011, 162:19-30.
27. Lee N., Wong C.K., Chan P.K., et al. Cytokine response patterns in severe pandemic 2009 H1N1 and seasonal influenza among hospitalized adults. PLoS One 2011, 6:e26050.
28. Lee N.L. Role of cytokines and chemokines in severe and complicated influenza infections. Hong Kong Med. J. 2009, 15(Suppl. 8):38-41.
29. Lippi G., Montagnana M., Favaloro E.J., Franchini M. Mental depression and cardiovascular disease: a multifaceted, bidirectional association. Semin. Thromb. Hemost. 2009, 35:325-336.
30. Meerlo P., Havekes R., Steiger A. Chronically restricted or disrupted sleep as a causal factor in the development of depression. Curr. Top Behav. Neurosci. 2015, 25:459-481.
31. Meier C.R., Napalkov P.N., Wegmuller Y., Jefferson T., Jick H. Population-based study on incidence, risk factors, clinical complications and drug utilisation associated with influenza in the United Kingdom. Eur. J. Clin. Microbiol. Infect. Dis. 2000, 19:834-842.
32. Miller A.H., Maletic V., Raison C.L. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol. Psychiatry 2009, 65:732-741.
33. Mineur Y.S., Picciotto M.R. Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis. Trends Pharmacol. Sci. 2010, 31:580-586.
34. Noah T.L., Zhou H., Jaspers I. Alteration of the nasal responses to influenza virus by tobacco smoke. Curr. Opin. Allergy Clin. Immunol. 2012, 12:24-31.
35. Pariante C.M., Orru M.G., Baita A., Farci M.G., Carpiniello B. Treatment with interferon-alpha in patients with chronic hepatitis and mood or anxiety disorders. Lancet 1999, 354:131-132.
36. Pedersen A.F., Zachariae R., Bovbjerg D.H. Psychological stress and antibody response to influenza vaccination: a meta-analysis. Brain Behav. Immun. 2009, 23:427-433.
37. Rait G., Walters K., Griffin M., Buszewicz M., Petersen I., Nazareth I. Recent trends in the incidence of recorded depression in primary care. Br. J. Psychiatry 2009, 195:520-524.
38. Richards J.M., Stipelman B.A., Bornovalova M.A., Daughters S.B., Sinha R., Lejuez C.W. Biological mechanisms underlying the relationship between stress and smoking: state of the science and directions for future work. Biol. Psychol. 2011, 88:1-12.
39. Rosenblat J.D., Brietzke E., Mansur R.B., Maruschak N.A., Lee Y., et al. Inflammation as a neurobiological substrate of cognitive impairment in bipolar disorder: evidence, pathophysiology and treatment implications. J. Affect. Disord. 2015, 188:149-159.
40. Schneider C., Jick S.S., Bothner U., Meier C.R. COPD and the risk of depression. Chest 2010, 137:341-347.
41. Segerstrom S.C., Hardy J.K., Evans D.R., Greenberg R.N. Vulnerability, distress, and immune response to vaccination in older adults. Brain Behav. Immun. 2012, 26:747-753.
42. Serrats J., Schiltz J.C., Garcia-Bueno B., van Rooijen N., Reyes T.M., Sawchenko P.E. Dual roles for perivascular macrophages in immune-to-brain signaling. Neuron 2010, 65:94-106.
43. Shah H., Kadia S., Bawa R., Lippmann S. Management of depression induced by interferon hepatitis therapies. Prim. Care Companion CNS Disord. 2013, 15.
44. Thapar A., Collishaw S., Pine D.S., Thapar A.K. Depression in adolescence. Lancet 2012, 379:1056-1067.
45. To K.K., Hung I.F., Li I.W., et al. Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection. Clin. Infect. Dis. 2010, 50:850-859.
46. Toovey S. Influenza-associated central nervous system dysfunction: a literature review. Travel Med. Infect. Dis. 2008, 6:114-124.
47. Toovey S., Jick S.S., Meier C.R. Parkinson's disease or Parkinson symptoms following seasonal influenza. Influenza Other Respir. Viruses 2011, 5:328-333.
48. Toovey S., Prinssen E.P., Rayner C.R., et al. Post-marketing assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: an updated review. Adv. Ther. 2012, 29:826-848.
49. Walters P., Schofield P., Howard L., Ashworth M., Tylee A. The relationship between asthma and depression in primary care patients: a historical cohort and nested case control study. PLoS One 2011, 6:e20750.
50. Warner-Schmidt J.L., Vanover K.E., Chen E.Y., Marshall J.J., Greengard P. Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans. Proc. Natl. Acad. Sci. USA 2011, 108:9262-9267.
51. Webb R.T., Kontopantelis E., Doran T., Qin P., Creed F., Kapur N. Suicide risk in primary care patients with major physical diseases: a case-control study. Arch. Gen. Psychiatry 2012, 69:256-264.